XDWF:F:F-Xtrackers (IE) Public Limited Company - Xtrackers MSCI World Financials UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 34.43

Change

0.00 (0.00)%

Market Cap

USD 0.41B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 43.00B
0ZC:F Zscaler Inc

-7.28 (-3.85%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing XDWF:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.87% 69% C- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.87% 68% D+ 62% D
Trailing 12 Months  
Capital Gain 33.63% 91% A- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.63% 87% B+ 69% C-
Trailing 5 Years  
Capital Gain 100.95% 91% A- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.95% 91% A- 64% D
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.41B 58% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike